TNF-α impairs EP4 signaling through the association of TRAF2-GRK2 in primary fibroblast-like synovio

来源 :中国药理学报(英文版) | 被引量 : 0次 | 上传用户:a84242936
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Our previous study showed that chronic treatment with tumor necrosis factor-α(TNF-α)decreased cAMP concentration in fibroblast-like synoviocytes(FLSs)of collagen-induced arthritis(CIA)rats.In this study we investigated how TNF-α impairs cAMP homeostasis,particularly clarifying the potential downstream molecules of TNF-α and prostaglandin receptor 4(EP4)signaling that would interact with each other.Using a cAMP FRET biosensor PM-ICUE3,we demonstrated that TNF-α(20 ng/mL)blocked ONO-4819-triggered EP4 signaling,but not Butaprost-triggered EP2 signaling in normal rat FLSs.We showed that TNF-α(0.02-20 ng/mL)dose-dependently reduced EP4 membrane distribution in normal rat FLS.TNF-α significantly increased TNF receptor 2(TNFR2)expression and stimulated proliferation in human FLS(hFLS)via ecruiting TNF receptor-associated factor 2(TRAF2)to cell membrane.More interestingly,we revealed that TRAF2 interacted with G protein-coupled receptor kinase(GRK2)in the cytoplasm of primary hFLS and helped to bring GRK2 to cell membrane in response of TNF-α stimulation,the complex of TRAF2 and GRK2 then separated on the membrane,and translocated GRK2 induced the desensitization and internalization of EP4,leading to reduced production of intracellular cAMP.Silencing of TRAF2 by siRNA substantially diminished TRAF2-GRK2 interaction,blocked the translocation of GRK2,and resulted in upregulated expression of membrane EP4 and intracellular cAMP.In CIA rats,administration of paroxetine to inhibit GRK2 effectively improved the symptoms and clinic parameters with significantly reduced joint synovium inflammation and bone destruction.These results elucidate a novel form of cross-talk between TNFR(a cytokine receptor)and EP4(a typical G protein-coupled receptor)signaling pathways.The interaction between TRAF2 and GRK2 may become a potential new drug target for the treatment of inflammatory diseases.
其他文献
We are pleased to present a Special Column on“Drug-and Chemical-induced Liver Injury”.The scope of articles in this issue is diverse,covering a wide range of unanswered questions in this research area faced by both clinicians and basic researchers.Liver i
期刊
目的:建立盐酸氨溴索口服液中抑菌剂及矫味剂含量测定方法并考察全国范围内该品种抑菌剂和矫味剂添加情况.方法:采用资生堂MGII C18(250 mm×4.6 mm,5μm)色谱柱,以0.02 mol·L-1乙酸铵溶液(用冰醋酸调节pH至4.5)-甲醇为流动相,梯度洗脱,流速1.0 mL·min-1,柱温为30℃,DAD检测器,检测波长为254 nm和230 nm.结果:盐酸氨溴索与4种抑菌剂、3种矫味剂色谱峰均能良好分离,并质量浓度分别在0.005~0.15 mg· mL-1范围内,苯甲酸钠(r=1.000
High mobility group box 1(HMGB1)is a ubiquitous nuclear protein that is present in almost all cells and regulates the activity of innate immune responses in both intracellular and extracellular settings.Current evidence suggests that HMGB1 plays a pivotal
Previous reports suggested that cinnamaldehyde(CA),the bioactive ingredient in Cinnamomum cassia,can suppress tumor growth,migratory,and invasive abilities.However,the role and molecular mechanisms of CA in GC are not completely understood.In the present
Hepatocellular carcinoma(HCC),the most prevalent liver cancer,is considered one of the most lethal malignancies with a dismal outcome mainly due to frequent intrahepatic and distant metastasis.In the present study,we demonstrated that oroxylin A,a natural
The tumor suppressor p53 is usually inactivated by somatic mutations in malignant neoplasms,and its reactivation represents an attractive therapeutic strategy for cancers.Here,we reported that a new quinolone compound RYL-687 significantly inhibited non-s
White matter injury is the major pathological alteration of subcortical ischemic vascular dementia(SIVD)caused by chronic cerebral hypoperfusion.It is characterized by progressive demyelination,apoptosis of oligodendrocytes and microglial activation,which
As a member of the potassium calcium-activated channel subfamily,increasing evidence suggests that KCNN4 was associated with malignancies.However,the roles and regulatory mechanisms of KCNN4 in PDAC have been little explored.In this work,we demonstrated t
Urate transporter 1(URAT1)and glucose transporter 9(GLUT9)are important targets for the development of uric acid-lowering drugs.We previously showed that the flexible linkers of URAT1 inhibitors could enhance their potency.In this study we designed and sy
Rheumatoid arthritis(RA)is a chronic systemic autoimmune disease characterized by synovitis and the destruction of small joints.Emerging evidence shows that immunoglobulin D(IgD)stimulation induces T-cell activation,which may contribute to diseases pathog